Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 8Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Sarcoma 7Lymphoma, Large B-Cell, Diffuse 6Osteosarcoma 3Lymphoma, B-Cell 3Sarcoma, Ewing 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Penile Neoplasms 2Neurofibrosarcoma 2Liposarcoma 2Hemangiosarcoma 2Fibrosarcoma 2Burkitt Lymphoma 2Wilms Tumor 1Vascular Neoplasms 1Teratoma 1Solitary Fibrous Tumors 1Smooth Muscle Tumor 1Sarcoma, Synovial 1Sarcoma, Endometrial Stromal 1Sarcoma, Clear Cell 1Rhabdomyosarcoma 1Recurrence 1Prostatic Neoplasms 1Pleuropulmonary blastoma 1Neuroblastoma 1Nerve Sheath Neoplasms 1Neoplasms, Adipose Tissue 1Neoplasm Metastasis 1Myoepithelioma 1Lymphoma, T-Cell, Peripheral 1

Interventions

Rituximab 22Lenalidomide 13orelabrutinib 12obinutuzumab 11Cyclophosphamide 9zanubrutinib 8fludarabine 7Magnetic Resonance Spectroscopy 5Bendamustine Hydrochloride 5venetoclax 4Specimen Handling 4Biopsy 4pirtobrutinib 3fludarabine phosphate 3Whole-Body Irradiation 2Vincristine 2Stem Cell Transplantation 2Prednisone 2Mycophenolic Acid 2CT-P10 2Automobiles 2treosulfan 1tafasitamab 1polatuzumab vedotin 1pemigatinib 1loncastuximab tesirine 1ibrutinib 1etoposide phosphate 1dexamethasone acetate 1dexamethasone 21-phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Lymphoma, B-Cell, Marginal Zone × Ifosfamide × Clear all
NCT06905509 2025-09-29

Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

University of California, Davis

Phase 2 Recruiting
25 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡